Longitudinal Molecular Monitoring
Interpretation of molecular change over time rather than at a single point.
- Patients with serial molecular or ctDNA results.
- Clinicians tracking molecular evolution during or after therapy.
- Serial molecular and ctDNA results
- Treatment timeline and documented response
- Emergence or disappearance of specific alterations
- Interpretation of the molecular trajectory
- Notes on possible resistance mechanisms where the data supports them
- Considerations for continued monitoring
- Analysis and interpretation are provided to you and, where you wish, directly to your treating team — who continue to prescribe, administer and direct your treatment.
- The work sits alongside your treating oncologist and is designed to strengthen that relationship rather than sit outside it.
- It is built for considered review. Anything acute or time-critical belongs with your treating team or your local emergency service, who can act immediately.
- It sets out what the evidence supports and where it remains uncertain. It does not forecast how a particular cancer will respond.
Getting started
Nothing is charged for an enquiry, and scope is agreed in writing before any work starts.
Enquiries begin with a short message describing the situation and the question. From there, the documentation needed is agreed, and a scope and timeline are confirmed before any work starts.
The document checklist sets out what is typically needed. Missing items are worth identifying at the outset rather than mid-review.